NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.88
0.21 (7.87%)
At close: Aug 15, 2025, 3:59 PM
2.87
-0.34%
After-hours: Aug 15, 2025, 07:40 PM EDT
NRx Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.59M | 8.9M | 14.97M | 16.51M | 20.05M | 18.25M | 24.55M | 40.2M | 27.61M | 38.88M | 13.39M | 232.00 |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.97M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.97M |
Other Long-Term Assets | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K | n/a |
Receivables | n/a | n/a | 6K | 6K | 6K | n/a | 6K | 6K | 6K | 7K | 547K | 554K | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | -6K | n/a | -6K | -6K | -7K | -547K | -554K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | 128K | n/a | n/a | n/a | 5.25M | 5.73M | 6.55M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 7.26M | 3.3M | 4.11M | 4.88M | 3.35M | 6.88M | 13.09M | 19.79M | 21.76M | 25.8M | 24.8M | 32.41M | 43.58M | 32.71M | 45.23M | 18.53M | 59.72K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K | 5.97M |
Total Assets | 7.59M | 3.65M | 4.46M | 5.26M | 3.79M | 7.32M | 13.11M | 19.81M | 21.78M | 25.82M | 24.82M | 32.43M | 43.6M | 32.73M | 45.25M | 18.55M | 6.03M |
Account Payables | 4.31M | 4.13M | 4.87M | 5.01M | 6.26M | 4.63M | 3.63M | 2.21M | 3.78M | 2.08M | 2.17M | 3.08M | 4.31M | 3.69M | 5.56M | 6.27M | 4.38K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 5.62M | 7.68M | n/a | n/a | n/a | n/a | n/a | 2.84M | 3.15M | 2.64M | -1.97M |
Short-Term Debt | 8.4M | 1.57M | 3.68M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 7.7M | n/a | n/a | 520K | 518K | 515.06K | 173.69K | 1.97M |
Other Current Liabilities | 15.12M | 10.93M | 11.35M | 9.6M | 5.32M | 4.42M | 324K | 6.77M | 5.17M | 5.81M | 5.87M | 4M | 7.08M | 7.72M | 30.21M | 29.03M | 47.26K |
Total Current Liabilities | 32.75M | 21.86M | 20.3M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 15.59M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.47M | 643.69K |
Long-Term Debt | n/a | 5.01M | 2.98M | n/a | n/a | n/a | n/a | n/a | n/a | 2.82M | n/a | n/a | n/a | n/a | n/a | 512.47K | 509.92K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.65M |
Total Long-Term Liabilities | n/a | 5.01M | 2.98M | n/a | 12.59M | n/a | n/a | n/a | 3.78M | 2.82M | 5.87M | 4M | 7.6M | 4.21M | n/a | 512.47K | 4.16M |
Total Liabilities | 32.75M | 26.87M | 23.28M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 18.41M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.98M | 4.81M |
Total Debt | 8.4M | 6.58M | 6.67M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 10.53M | n/a | n/a | 520K | 518K | 515.06K | 686.17K | 2.85M |
Common Stock | 17K | 15K | 11K | 11K | 10K | 84K | 84K | 80K | 70K | 67K | 68K | 67K | 67K | 59K | 54.81K | 48.6K | 2.69K |
Retained Earnings | -283.79M | -278.27M | -269.19M | -267.57M | -259.68M | -253.15M | -248.81M | -242.75M | -234.04M | -223M | -212.76M | -203.67M | -196.69M | -183.24M | -152.45M | -131.68M | -1.61M |
Comprehensive Income | n/a | n/a | n/a | -3K | -3K | -3K | -22K | -22K | 106K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.69K |
Shareholders Equity | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M | -284K | 7.41M | 16.78M | 25.35M | 31.69M | 20.81M | 8.97M | -17.44M | 1.22M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.97M |